The Monitoring Program includes substances which are not on the Prohibited List, but that WADA wishes to monitor in order to detect potential patterns of misuse in sport. A spokesperson for Novo Nordisk said in a statement that the pharmaceutical company, which produces and distributes GLP-1s, agreed with WADAs decision to monitor GLP-1 usage: We are supportive of the WADA recommendation, and we strongly discourage use/promotion outside the indicated population and approved label. Advertisement A spokesperson for Eli Lilly, another company that manufactures and distributes GLP-1s, said: Zepbound (tirzepatide) and Foundayo (orforglipron) are indicated for use, along with diet and exercise, for adults with obesity or overweight and a weight-related comorbidity
What About Rybelsus, Oral Semaglutide, Oral Tirzepatide, Liraglutide, or GLP-1 Supplements
I have been using it for over three months and feel great
That constraint matters for the 160-plus million Americans who get insurance through their employers which is precisely why Cuban has pushed so hard into the employer market
it can ruin a lot of clothes